Minimally Invasive Treatment of Recurrent Varicose Veins with Thrombotic Complications

  • Serhii P. Shchukin Bogomolets National Medical University, Kyiv, Ukraine; LTD "Medical Center of Phlebology and aesthetic medicine “Phlebos”, Kyiv, Ukraine. https://orcid.org/0009-0005-3232-2340
DOI: https://doi.org/10.63181/ujcvs.2025.33(4).127-135
Keywords: saphenous vein insufficiency, anterior accessory saphenous vein (AASV), superficial vein thrombosis, endovenous thermal ablation, ultrasound-guided foam sclerotherapy, radiofrequency catheter ablation, perforator vein incompetence, quality-of-life outcomes

Abstract

Background. Recurrent varicose vein disease (RVVD) remains a frequent problem after surgery or endovenous ablation (≈13-65 %). Mechanisms include residual reflux, de novo varicosities, and neovascularization. When RVVD is complicated by superficial vein thrombosis (SVT), treatment becomes challenging because current guidelines focus mainly on anticoagulation and rarely address reflux correction.

Aim. To evaluate the feasibility, safety, and effectiveness of combined minimally invasive therapy for RVVD complicated by SVT.

Materials and Methods. This single-center cohort included 31 patients (24 women, 7 men; mean age 55±13 years) with duplex-verified SVT and RVVD (CEAP C2r–C6r) treated between 2013 and 2025. Interventions comprised endovenous laser or radiofrequency ablation (EVLA/RFA), ultrasound-guided foam sclerotherapy (UGFS), and miniphlebectomy (MF), individually or in combination. Short-term rivaroxaban (15-20 mg/day for 20-45 days) was prescribed for SVT. Primary endpoints: segment occlusion, reflux elimination, thrombus regression, recurrence, and complications (EHIT/DVT/PE). Secondary endpoints: changes in VCSS, CIVIQ-14, VDS, and VDSS.

Results. Great saphenous vein (GSV) reflux occurred in 20 (65 %) patients, small saphenous vein (SSV) reflux in 15 (48 %) patients, and perforator incompetence in 23 (74 %). Neovascularization at the SFJ/SPJ was detected in 10 (32 %), confirming true recurrence. EVLA was performed in 29/31 patients, usually with UGFS ± MF. Clinical improvement was significant: mean VCSS decreased from 5.5 to 2.1, and CIVIQ-14 from 35.2 to 22.2 (p<0.001). No EHIT ≥ II, DVT, or PE occurred. Duplex confirmed thrombus regression in 94 % of cases.

Conclusions. Combined minimally invasive treatment (EVLA/RFA + UGF±MF) is a feasible, safe, and effective option for RVVD complicated by SVT. This reflux-directed, office-based approach ensures durable anatomic success, rapid recovery, and meaningful quality-of-life improvement.

References

  1. Perrin MR, Guex JJ, Ruckley CV, dePalma RG, Royle JP, Eklof B, Nicolini P, Jantet G. Recurrent varices after surgery (REVAS), a consensus document. Cardiovasc Surg. 2000;8(4):233–245. doi:10.1177/096721090000800402
  2. Borecka‑Sobczak J, Musińska A. Neovascularization in the groin: treatment options. Phlebological Review. 2024;32(1):26‑31. https://doi.org/10.5114/pr.2024.152007.
  3. Whing J, Nandhra S, Nesbitt C, Stansby G. Interventions for great saphenous vein incompetence. Cochrane Database Syst Rev. 2021;8:CD005624. https://doi.org/10.1002/14651858.CD005624.pub4
  4. Zollmann M, Zollmann C, Zollmann P, Veltman J, Cramer P, Stüecker M. Recurrence types 3 years after endovenous thermal ablation in insufficient saphenofemoral junctions. J Vasc Surg Venous Lymphat Disord. 2021;9(1):137‑145. https://doi.org/10.1016/j.jvsv.2020.04.021
  5. Baccellieri D, Nano G, Pedrini L, et al. Factors influencing recurrent varicose vein formation after radiofrequency thermal ablation for truncal reflux performed in two high‑volume venous centers. J Vasc Surg Venous Lymphat Disord. 2024;12(1):101670. https://doi.org/10.1016/j.jvsv.2023.08.014
  6. Yun S, Hwang MO. Post‑Operative Follow‑Up with Ultrasound after Varicose Vein Ablation. Ann Phlebology. 2023;21(2):85‑89. https://doi.org/10.37923/phle.2023.21.2.85
  7. De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black SA, Blomgren L, et al. Editor’s Choice – European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg. 2022;63(2):184–267. doi:10.1016/j.ejvs.2021.12.024
  8. Yamashita Y, Morimoto T, Kadota K, Takase T, Hiramori S, Kim K, et al. Clinical characteristics, management strategies and outcomes of patients with recurrent venous thromboembolism in the real world. Sci Rep. 2022;12:22437. https://doi.org/10.1038/s41598-022-26947-9
  9. Di Minno MN, Ambrosino P, Ambrosini F, Tremoli E, Di Minno G, Dentali F. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost. 2016;14(5):964–972. https://doi.org/10.1111/jth.13279
  10. Galanaud JP, Sevestre MA, Pernod G, Kahn SR, Genty C, Terrisse H, et al. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis. J Thromb Haemost. 2017;15(6):1123–1131. https://doi.org/10.1111/jth.13679
  11. Cannegieter SC, Horváth-Puhó E, Schmidt M, Dekkers OM, Pedersen L, Vandenbroucke JP, Sørensen HT. Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis: a nationwide cohort study. Blood. 2015;125(2):229–235. https://doi.org/10.1182/blood-2014-06-577783
  12. Barco S, Pomero F, Di Minno MND, Tamborini Permunian E, Malato A, Pasca S, et al. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study. J Thromb Haemost. 2017;15(11):2176–2183. https://doi.org/10.1111/jth.13840
  13. Nicolaides AN, Kakkos SK, Baekgaard N, Comerota AJ, De Maeseneer MG, Eklof B, et al. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. Int Angiol. 2020;39(3):175–240. https://doi.org/10.23736/S0392-9590.18.03999-8
  14. Stevens SM, Woller SC, Baumann Kreuziger L, Doerschug K, Geersing GJ, Klok FA, King CS, Murin S, Vintch JRE, Wells PS, Wasan S, Moores LK. Antithrombotic therapy for VTE disease: compendium and review of CHEST guidelines 2012–2021. Chest. 2024;166(2):388–404. https://doi.org/10.1016/j.chest.2024.03.003
  15. Kakkos SK, Gohel M, Baekgaard N, Bauersachs R, Bellmunt-Montoya S, Black SA, et al. European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis. Eur J Vasc Endovasc Surg. 2021;61(1):9–82. https://doi.org/10.1016/j.ejvs.2020.09.023
  16. Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, Cuker A, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693–4738. https://doi.org/10.1182/bloodadvances.2020001830
  17. Rabe E, Hoffmann U, Schimke A, Heinken A, Langer F, Noppeney T, et al. Determinants of late venous thromboembolic events after acute isolated superficial vein thrombosis in daily practice: 12-month results of the INSIGHTS-SVT study. Eur J Vasc Endovasc Surg. 2023;66(5):697–704. https://doi.org/10.1016/j.ejvs.2023.08.031
  18. Wong M, Parsi K, Myers K, De Maeseneer M, Caprini J, Cavezzi A, et al. Sclerotherapy of lower limb veins: indications, contraindications and strategies to prevent complications—A consensus document of the International Union of Phlebology (2023). Phlebology. 2023;38(4):205–258. https://doi.org/10.1177/02683555231151350
  19. Gloviczki P, Lawrence P, Wasan S, Meissner M, Almeida J, Brown KR, Bush RL, Di Iorio M, Fish J, Fukaya E, Gloviczki ML, Hingorani A, Jayaraj A, Kolluri R, Murad MH, Obi AT, Ozsvath K, Singh MJ, Vayuvegula S, Welch H. Duplex Scanning and Treatment of Superficial Truncal Reflux: Endorsed by the Society for Vascular Medicine and the International Union of Phlebology. J Vasc Surg Venous Lymphat Disord. 2023 Mar;11(2):231-261.e6. https://doi.org/10.1016/j.jvsv.2022.09.004
  20. Di Nisio M, Camporese G, Di Micco P, Martini R, Ageno W, Prandoni P. Treatment of Superficial Vein Thrombosis: Recent Advances, Unmet Needs and Future Directions. Healthcare. 2024;12(15):1517. https://doi.org/10.3390/healthcare12151517
  21. Gloviczki P, Lawrence PF, Wasan SM, Meissner MH, Almeida J, Brown KR, et al. The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine. J Vasc Surg Venous Lymphat Disord. 2024;12(1):101670. https://doi.org/10.1016/j.jvsv.2023.08.011
  22. Darwis P, Pratama D, Muradi A, Hamzah A, Rizqhi F, Satriadinatha GB. Adaptation of the CIVIQ-20 Questionnaire as a measurement instrument on quality-of-life in chronic venous insufficiency patients in Jakarta, Indonesia. Chirurgia. 2024;37(4):243–246. https://doi.org/10.23736/S0394-9508.23.05666-8
  23. Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord. 2020;8(3):342–352. https://doi.org/10.1016/j.jvsv.2019.12.075
  24. Bontinis A, Bontinis V, Koudounas G, et al. Interventions for the treatment of recurrent varicose vein disease arising from the saphenofemoral junction or the great saphenous vein: a systematic review and meta‑analysis. Int Angiol. 2024;43(5):485‑496. https://doi.org/10.23736/S0392-9590.24.05323-9
  25. Brittenden J, Cotton SC, Elders A, Ramsay CR, Norrie J, Burr J, et al. Five-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins. N Engl J Med. 2019;381(10):912–922. https://doi.org/10.1056/NEJMoa1805186
Published
2025-12-25
How to Cite
1.
Shchukin SP. Minimally Invasive Treatment of Recurrent Varicose Veins with Thrombotic Complications. ujcvs [Internet]. 2025Dec.25 [cited 2025Dec.26];33(4):127-35. Available from: http://cvs.org.ua/index.php/ujcvs/article/view/801
Issue
Ukrainian Journal of Cardiovascular Surgery Vol 33 No 4 2025
Section
PATHOLOGY OF THE PERIPHERAL VASCULAR SYSTEM